Aug 13, 2025 08:27AM
Aug 13, 2025 07:30AM
Jul 28, 2025 07:33AM
Jul 28, 2025 07:30AM
May 13, 2025 05:47PM
May 13, 2025 07:30AM
May 7, 2025 12:00PM Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
Apr 1, 2025 06:47AM
Mar 12, 2025 04:54PM
Nov 14, 2024 06:59AM
Nov 13, 2024 09:02PM
Nov 13, 2024 04:05PM
Oct 31, 2024 05:20PM
Aug 12, 2024 07:11AM Adaptimmune Therapeutics (ADAP) Tops Q2 EPS by 9c
Aug 12, 2024 07:00AM
Aug 5, 2024 08:00AM
May 15, 2024 07:30AM
May 1, 2024 12:00PM
Mar 6, 2024 07:00AM
Feb 21, 2024 04:00PM
Nov 8, 2023 07:41AM Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 14c
Nov 8, 2023 07:30AM
Oct 25, 2023 08:06AM
Aug 9, 2023 07:59AM
Aug 9, 2023 07:29AM
Aug 3, 2023 01:24PM
Jun 1, 2023 03:29PM
May 16, 2023 07:00AM AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer
May 12, 2023 07:32AM
May 12, 2023 07:29AM
Apr 28, 2023 12:00PM
Mar 23, 2023 06:30AM
Mar 6, 2023 07:12AM
Mar 6, 2023 06:33AM
Mar 6, 2023 06:30AM Adaptimmune Reports Fourth-Quarter and Full Year Financial Results and Business Update
Mar 6, 2023 06:01AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
Feb 22, 2023 08:00AM
Nov 9, 2022 03:46PM
Nov 8, 2022 07:30AM Adaptimmune Reports Third-Quarter Financial Results and Business Update
Oct 27, 2022 12:27PM
Aug 4, 2022 07:30AM
Jul 21, 2022 08:00AM
May 9, 2022 07:30AM
Apr 28, 2022 04:30PM
Mar 14, 2022 08:00AM
Mar 8, 2022 12:35PM Adaptimmune to Report Q4 and Full Year 2021 Financial Results and Business Updates on Monday, March 14, 2022
Nov 15, 2021 07:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All